Literature DB >> 10852794

Respiratory control and respiratory sensation in a patient with a ganglioglioma within the dorsocaudal brain stem.

H L Manning1, J C Leiter.   

Abstract

We encountered a young woman with severe central sleep apnea caused by a medullary glioma located slightly dorsal to and to the right of the midline, a region not generally associated with CO(2) chemosensitivity. The patient had normal spirometric readings, lung volumes, diffusing capacity, maximal inspiratory pressure, and alveolar-arterial oxygen difference. While awake, she displayed marked irregularity in her breathing pattern; her end-tidal CO(2) (FET(CO(2))) ranged from 5.3 to 10.9%. During voluntary hyperpnea, she could quickly reduce her FET(CO(2)) to 4.2%, but her PCO(2) did not change after administration of acetazolamide or progesterone. Like patients with congenital central hypoventilation syndrome (CCHS), our patient had a relatively intact ventilatory response to exercise; her PCO(2) was high at the start of exercise and increased slightly thereafter. In contrast to CCHS patients, however, our patient had an intact hypoxic ventilatory response (DeltaVE/ DeltaSa(O(2)) = -0.37 L/min/Sa(O(2))). In further contrast to CCHS patients, our patient had a very short breathholding time and described a sensation of air hunger as the factor limiting her breathholding ability. Her heart rate and blood pressure responses to the Valsalva maneuver were normal.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10852794     DOI: 10.1164/ajrccm.161.6.9904087

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  9 in total

1.  Ganglioglioma in brainstem : case report and a review of literatures.

Authors:  Sung-Duk Kim; Jong Hyun Kim; Cheol-Young Lee; Hyun-Woo Kim
Journal:  J Korean Neurosurg Soc       Date:  2014-03-31

2.  An unusual cause of insomnia. Central sleep apnea (CSA).

Authors:  Tauseef Afaq; Ulysses J Magalang; Aneesa M Das
Journal:  J Clin Sleep Med       Date:  2012-10-15       Impact factor: 4.062

3.  Brainstem gangliogliomas: prognostic factors, surgical indications and functional outcomes.

Authors:  Chang-Cun Pan; Xin Chen; Cheng Xu; Wen-Hao Wu; Peng Zhang; Yu Wang; Tao Wu; Jie Tang; Xin-Ru Xiao; Zhen Wu; Jun-Ting Zhang; Li-Wei Zhang
Journal:  J Neurooncol       Date:  2016-04-25       Impact factor: 4.130

4.  Pediatric brainstem gangliogliomas show overexpression of neuropeptide prepronociceptin (PNOC) by microarray and immunohistochemistry.

Authors:  Michael H Chan; B K Kleinschmidt-Demasters; Andrew M Donson; Diane K Birks; Nicholas K Foreman; Sarah Z Rush
Journal:  Pediatr Blood Cancer       Date:  2012-06-15       Impact factor: 3.167

5.  Pediatric brainstem gangliogliomas show BRAF(V600E) mutation in a high percentage of cases.

Authors:  Andrew M Donson; Bette K Kleinschmidt-DeMasters; Dara L Aisner; Lynne T Bemis; Diane K Birks; Jean M Mulcahy Levy; Amy A Smith; Michael H Handler; Nicholas K Foreman; Sarah Z Rush
Journal:  Brain Pathol       Date:  2013-12-23       Impact factor: 6.508

6.  Germ cell tumors of the brainstem: report on two cases with pulmonary complications and a review of the literature.

Authors:  Jenny Madden; Nicholas K Foreman; Arthur K Liu
Journal:  J Neurooncol       Date:  2009-01-13       Impact factor: 4.130

7.  Ultrasonographic diaphragmatic motion analysis and its correlation with pulmonary function in hemiplegic stroke patients.

Authors:  Kang-Jae Jung; Ji-Young Park; Do-Won Hwang; Jeong-Hawn Kim; Jae-Hyung Kim
Journal:  Ann Rehabil Med       Date:  2014-02-25

8.  Ondine's curse: myth meets reality.

Authors:  Zeferino Demartini; Luana Antunes Maranha Gatto; Gelson Luis Koppe; Alexandre Novicki Francisco; Enio Eduardo Guerios
Journal:  Sleep Med X       Date:  2020-07-13

Review 9.  Sleep-Disordered Breathing in People with Multiple Sclerosis: Prevalence, Pathophysiological Mechanisms, and Disease Consequences.

Authors:  Hanna A Hensen; Arun V Krishnan; Danny J Eckert
Journal:  Front Neurol       Date:  2018-01-15       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.